Effect of adenovirus-mediated RNA interference of IL-1β expression on spinal cord injury in rats

Spinal Cord
W-P LinQ-F Ke

Abstract

We introduced an adenoviral vector expressing interleukin-1β (IL-1β) small-hairpin RNA (shRNA) into the injured spinal cords to evaluate the therapeutic potential of IL-1β downregulation in a rat model of spinal cord injury (SCI). The purpose of this study was to investigate the possible protective effects of the IL-1β downregulation on traumatic SCI in rats. Department of Orthopedic Surgery, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, People's Republic of China. An adenoviral shRNA targeting IL-1β was constructed and injected at the T12 section 7 days before SCI. The rats' motor functions were evaluated by the Basso-Beattie-Bresnahan (BBB) rating scale. Immunofluorescence, enzyme-linked immunosorbent assay, flow-cytometric analysis and western blots were also performed. Animals downregulating IL-1β had significantly better recovery of locomotor function and less neuronal loss after SCI. In addition, IL-1β downregulation significantly decreased tumor necrosis factor-alpha (TNF-α) level and Bax expression, reduced the activity of caspase-3 and increased Bcl-2 expression after SCI. This study demonstrated that the IL-1β downregulation may have potential therapeutic benefits for both reducing secondary dam...Continue Reading

References

Feb 1, 1995·Journal of Neurotrauma·D M BassoJ C Bresnahan
Jan 1, 1997·Annual Review of Neuroscience·D E Merry, S J Korsmeyer
Aug 13, 1999·Genes & Development·A GrossS J Korsmeyer
Sep 29, 1999·Neuroreport·L C EhrlichS Hu
Oct 24, 2000·Brain Research. Developmental Brain Research·S M Mooney, M W Miller
Mar 23, 2002·Science·Thijn R BrummelkampReuven Agami
May 29, 2002·Brain Research Bulletin·Armin BleschMark H Tuszynski
Jul 12, 2002·Journal of Neuroscience Research·Jonathan Z PanRonald P Hart
Jan 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Gustavo TiscorniaInder M Verma
Jun 20, 2003·Spinal Cord·O N Hausmann
Nov 30, 2004·Trends in Molecular Medicine·Michael S Beattie
Sep 15, 2007·Nature Protocols·Amanda BirminghamAnastasia Khvorova
Apr 28, 2009·Advanced Drug Delivery Reviews·Sang-Kyung Lee, Priti Kumar
Nov 28, 2012·Journal of Molecular Neuroscience : MN·Jinlong ZhangZhiming Cui

❮ Previous
Next ❯

Citations

Jul 18, 2017·Human Gene Therapy Methods·Elena Herrera-CarrilloBen Berkhout
Mar 2, 2017·Scientific Data·Weilin WuRalph A Tripp
Jan 13, 2018·Molecular Medicine Reports·Zhi-Rong ChenQun-Hua Jin

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.